We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.4B
AUM Growth
+$3.53B
(+32%)
Cap. Flow
+$2.81B
Cap. Flow
% of AUM
19.5%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
1,820
New
468
Increased
1,221
Reduced
109
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$116M |
| 3 |
Amazon
AMZN
|
+$84.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.3M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$6.62M |
| 3 |
VF Corp
VFC
|
+$4.38M |
| 4 |
W.W. Grainger
GWW
|
+$3.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.64% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Staples | 10.45% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Markel Group
MKL
$24.7B
| $2.33M | 0.02% |
2,047
+117
| +6% | +$128K |
|
|
CLVS
577
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.33M | 0.02% |
34,250
+2,539
| +8% | +$178K |
|
|
AVXS
578
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.31M | 0.02% |
20,877
+1,178
| +6% | +$118K |
|
579
Douglas Emmett
DEI
$2.04B
| $2.29M | 0.02% |
55,787
+10,303
| +23% | +$416K |
|
580
F5
FFIV
$22B
| $2.24M | 0.02% |
17,051
+6,942
| +69% | +$862K |
|
581
Akamai
AKAM
$17.1B
| $2.24M | 0.02% |
34,386
-50,209
| -59% | -$2.78M |
|
582
Global Payments
GPN
$21.7B
| $2.23M | 0.02% |
22,228
+7,960
| +56% | +$796K |
|
|
LPT
583
DELISTED
Liberty Property Trust
LPT
| $2.22M | 0.02% |
51,675
+7,837
| +18% | +$340K |
|
584
Hilton Worldwide
HLT
$73.9B
| $2.22M | 0.02% |
27,805
+8,590
| +45% | +$637K |
|
|
PTLA
585
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.21M | 0.02% |
45,355
+7,572
| +20% | +$383K |
|
586
AES
AES
$10.6B
| $2.2M | 0.02% |
203,225
+33,750
| +20% | +$365K |
|
|
ANSS
587
DELISTED
Ansys
ANSS
| $2.19M | 0.02% |
14,811
+3,226
| +28% | +$457K |
|
588
Lamar Advertising Co
LAMR
$16B
| $2.18M | 0.02% |
29,409
+4,572
| +18% | +$333K |
|
|
Y
589
DELISTED
Alleghany Corp
Y
| $2.15M | 0.01% |
3,600
+479
| +15% | +$273K |
|
590
Ligand Pharmaceuticals
LGND
$6.01B
| $2.14M | 0.01% |
25,047
+2,332
| +10% | +$202K |
|
|
LVNTA
591
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $2.13M | 0.01% |
39,215
+12,871
| +49% | +$733K |
|
592
Newell Brands
NWL
$2.14B
| $2.1M | 0.01% |
68,032
+22,629
| +50% | +$780K |
|
593
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.1M | 0.01% |
69,563
-1,682
| -2% | -$53.8K |
|
594
AGNC Investment
AGNC
$12.3B
| $2.09M | 0.01% |
103,571
+12,714
| +14% | +$261K |
|
595
DaVita
DVA
$15.2B
| $2.08M | 0.01% |
28,796
-20,512
| -42% | -$1.26M |
|
596
CMS Energy
CMS
$23.2B
| $2.08M | 0.01% |
43,975
+13,820
| +46% | +$669K |
|
|
BPMC
597
DELISTED
Blueprint Medicines
BPMC
| $2.07M | 0.01% |
27,435
+2,731
| +11% | +$192K |
|
|
GAP
598
The Gap Inc
GAP
$6.8B
| $2.06M | 0.01% |
60,575
+9,775
| +19% | +$291K |
|
|
STL
599
DELISTED
Sterling Bancorp
STL
| $2.06M | 0.01% |
83,801
+53,500
| +177% | +$1.33M |
|
600
Equity Lifestyle Properties
ELS
$12.9B
| $2.06M | 0.01% |
46,312
+5,730
| +14% | +$255K |
|
Similar funds
ProShare Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ProShare Advisors held 1,820 positions worth $14.4B, up 32% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors deployed $2.81B of net new capital in Q4 2017, opening 468 new positions and adding to 1,221 existing holdings. Its largest new stake was ASML: 31,220 shares worth $5.43M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VF Corp, an estimated $4.38M trimmed.
- ProShare Advisors's largest Q4 2017 buy was ASML: 31,220 shares worth $5.43M.
- ProShare Advisors added most to Apple in Q4 2017, an estimated $160M increase.
- ProShare Advisors's biggest Q4 2017 reduction was VF Corp, cutting an estimated $4.38M.
- ProShare Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.3M.
- ProShare Advisors's ten largest holdings make up 18% of its $14.4B portfolio in Q4 2017.
- ProShare Advisors opened 468 new positions and closed 21 in Q4 2017.
- ProShare Advisors's portfolio value rose 32% quarter-over-quarter to $14.4B.
Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.